GlucoSure™ a brand under Apex Biotecnology Corporation Taiwan, has been a pioneer in home care medical devices since ApexBio’s establishment in December 1997. Leveraging biosensor technology, GlucoSure™ specializes in developing self-testing handheld devices for chronic disease patients, offering solutions for monitoring blood glucose, uric acid, hemoglobin, cholesterol, lactate, HbA1C, ketone, coagulation, and multifunctional health testing. As part of ApexBio, GlucoSure™ maintains a commitment to quality, with its products approved by regulatory bodies such as CE, FDA, TFDA, CFDA, ANVISA. The manufacturing facilities adhere to stringent standards, including Taiwan GMP, Brazil GMP, ISO 9001 & 13485, and FDA regulations. Apex Biotechnology Corporation, the first IPO-listed biotechnology company in Taiwan, in 2000, continues to lead in the research, development, manufacture, and global sales of innovative in vitro diagnostic solutions.
